An Intraoperative Sub-Anesthetic Dose of Esketamine on Postoperative Depressive Symptoms in Perimenopausal Women with Breast Cancer Undergoing Modified Radical Mastectomy: Protocol for a Randomized, Triple-Blinded, Controlled Trial

References

• Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15–23. doi:10.1016/j.breast.2022.08.010
   PubMed Web of Science ®Google Scholar
• Carreira H, Williams R, Funston G, Stanway S, Bhaskaran K. Associations between breast cancer survivorship and adverse mental health outcomes: a matched population-based cohort study in the United Kingdom. PLoS Med. 2021;18(1):e1003504. doi:10.1371/journal.pmed.1003504
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim SW, Shin IS, et al. Changes in depression status during the year after breast cancer surgery and impact on quality of life and functioning. Gen Hosp Psychiatry. 2018;50:33–37. doi:10.1016/j.genhosppsych.2017.09.009
   PubMed Web of Science ®Google Scholar
• Maass SW, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review. Maturitas. 2015;82(1):100–108. doi:10.1016/j.maturitas.2015.04.010
   PubMed Web of Science ®Google Scholar
• Tang R, Luo M, Li J, et al. Symptoms of anxiety and depression among Chinese women transitioning through menopause: findings from a prospective community-based cohort study. Fertil Steril. 2019;112(6):1160–1171. doi:10.1016/j.fertnstert.2019.08.005
   PubMed Web of Science ®Google Scholar
• Yang Y, Cui Y, Sang K, et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature. 2018;554(7692):317–322. doi:10.1038/nature25509
   PubMed Web of Science ®Google Scholar
• Smith-Apeldoorn SY, Veraart JK, Spijker J, Kamphuis J, Schoevers RA. Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability. Lancet Psychiatry. 2022;9(11):907–921. doi:10.1016/S2215-0366(22)00317-0
   PubMed Web of Science ®Google Scholar
• Hirota K, Lambert DG. Ketamine and depression. Br J Anaesth. 2018;121(6):1198–1202. doi:10.1016/j.bja.2018.08.020
   PubMed Web of Science ®Google Scholar
• Johnston JN, Henter ID, Zarate CA Jr. The antidepressant actions of ketamine and its enantiomers. Pharmacol Ther. 2023;246:108431. doi:10.1016/j.pharmthera.2023.108431
   PubMed Web of Science ®Google Scholar
• Kim J, Farchione T, Potter A, Chen Q, Temple R. Esketamine for treatment-resistant depression - first FDA-approved antidepressant in a new class. N Engl J Med. 2019;381(1):1–4. doi:10.1056/NEJMp1903305
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383–399. doi:10.1176/appi.ajp.2020.20081251
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Xu X, Peng S, Xu F, Liu P. Use of various doses of S-ketamine in treatment of depression and pain in cervical carcinoma patients with mild/moderate depression after laparoscopic total hysterectomy. Med Sci Monit. 2020;26:e922028. doi:10.12659/MSM.922028
   PubMed Web of Science ®Google Scholar
• Guo J, Qiu D, Gu HW, et al. Efficacy and safety of perioperative application of ketamine on postoperative depression: a meta-analysis of randomized controlled studies. Mol Psychiatry. 2023. doi:10.1038/s41380-023-01945-z
   Web of Science ®Google Scholar
• Wang J, Sun Y, Ai P, et al. The effect of intravenous ketamine on depressive symptoms after surgery: a systematic review. J Clin Anesth. 2022;77:110631. doi:10.1016/j.jclinane.2021.110631
   PubMed Web of Science ®Google Scholar
• Gan SL, Long YQ, Wang QY, et al. Effect of esketamine on postoperative depressive symptoms in patients undergoing thoracoscopic lung cancer surgery: a randomized controlled trial. Front Psychiatry. 2023;14:1128406. doi:10.3389/fpsyt.2023.1128406
   PubMed Web of Science ®Google Scholar
• Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension. JAMA. 2018;319(5):483–494. doi:10.1001/jama.2017.21903
   PubMed Web of Science ®Google Scholar
• Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7:151–169. doi:10.1159/000395074
   PubMedGoogle Scholar
• Fan N, Xu K, Ning Y, et al. Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users. Psychiatry Res. 2016;237:311–315. doi:10.1016/j.psychres.2016.01.023
   PubMed Web of Science ®Google Scholar
• Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371–379. doi:10.1016/S0033-3182(71)71479-0
   PubMed Web of Science ®Google Scholar
• Dunstan DA, Scott N. Norms for Zung’s Self-rating Anxiety Scale. BMC Psychiatry. 2020;20(1):90. doi:10.1186/s12888-019-2427-6
   PubMed Web of Science ®Google Scholar
• Geng Y, Gao T, Zhang X, Wang Y, Zhang Z. The association between disease duration and mood disorders in rheumatoid arthritis patients. Clin Rheumatol. 2022;41(3):661–668. doi:10.1007/s10067-021-05967-2
   PubMed Web of Science ®Google Scholar
• Genc C, Kaya C, Bilgin S, Dost B, Ustun YB, Koksal E. Pectoserratus plane block versus erector spinae plane block for postoperative opioid consumption and acute and chronic pain after breast cancer surgery: a randomized controlled trial. J Clin Anesth. 2022;79:110691. doi:10.1016/j.jclinane.2022.110691
   PubMed Web of Science ®Google Scholar
• Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013;118(6):1332–1340. doi:10.1097/ALN.0b013e318289b84b
   PubMed Web of Science ®Google Scholar
• Wessels E, Perrie H, Scribante J, Jooma Z. Quality of recovery in the perioperative setting: a narrative review. J Clin Anesth. 2022;78:110685. doi:10.1016/j.jclinane.2022.110685
   PubMed Web of Science ®Google Scholar
• Kleif J, Gogenur I. Severity classification of the quality of recovery-15 score-an observational study. J Surg Res. 2018;225:101–107. doi:10.1016/j.jss.2017.12.040
   PubMed Web of Science ®Google Scholar
• Tao Y, Yu H, Liu S, et al. Hope and depression: the mediating role of social support and spiritual coping in advanced cancer patients. BMC Psychiatry. 2022;22(1):345. doi:10.1186/s12888-022-03985-1
   PubMed Web of Science ®Google Scholar
• Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi:10.1136/bmj.c869
   PubMed Web of Science ®Google Scholar
• de Kruif M, Spijker AT, Molendijk ML. Depression during the perimenopause: a meta-analysis. J Affect Disord. 2016;206:174–180. doi:10.1016/j.jad.2016.07.040
   PubMed Web of Science ®Google Scholar
• Grub J, Suss H, Willi J, Ehlert U. Steroid hormone secretion over the course of the perimenopause: findings from the swiss perimenopause study. Front Glob Womens Health. 2021;2:774308. doi:10.3389/fgwh.2021.774308
   PubMedGoogle Scholar
• Ren Q, Hua L, Zhou X, et al. Effects of a single sub-anesthetic dose of ketamine on postoperative emotional responses and inflammatory factors in colorectal cancer patients. Front Pharmacol. 2022;13:818822. doi:10.3389/fphar.2022.818822
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang WH, Lu YX, et al. Intraoperative low-dose S-ketamine reduces depressive symptoms in patients with crohn’s disease undergoing bowel resection: a randomized controlled trial. J Clin Med. 2023;12(3):1152.
   PubMed Web of Science ®Google Scholar
• Liu P, Li P, Li Q, et al. Effect of pretreatment of S-ketamine on postoperative depression for breast cancer patients. J Invest Surg. 2021;34(8):883–888. doi:10.1080/08941939.2019.1710626
   PubMed Web of Science ®Google Scholar
• Correia-Melo FS, Leal GC, Vieira F, et al. Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study. J Affect Disord. 2020;264:527–534. doi:10.1016/j.jad.2019.11.086
   PubMed Web of Science ®Google Scholar
• Gastaldon C, Raschi E, Kane JM, Barbui C, Schoretsanitis G. Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system. Psychother Psychosom. 2021;90(1):41–48. doi:10.1159/000510703
   PubMed Web of Science ®Google Scholar
• Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50(4):260–265. doi:10.1016/s0006-3223(01)01083-6
   PubMed Web of Science ®Google Scholar
• Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10(9):1089–1093. doi:10.1038/nn1971
   PubMed Web of Science ®Google Scholar
• Medeiros GC, Gould TD, Prueitt WL, et al. Blood-based biomarkers of antidepressant response to ketamine and esketamine: a systematic review and meta-analysis. Mol Psychiatry. 2022;27(9):3658–3669. doi:10.1038/s41380-022-01652-1
   PubMed Web of Science ®Google Scholar
• Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS. BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol. 2014;18(1):pyu033.
   PubMed Web of Science ®Google Scholar
• Li N, Lee B, Liu RJ, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329(5994):959–964. doi:10.1126/science.1190287
   PubMed Web of Science ®Google Scholar
• Carreira H, Williams R, Muller M, Harewood R, Stanway S, Bhaskaran K. Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. J Natl Cancer Inst. 2018;110(12):1311–1327. doi:10.1093/jnci/djy177
   PubMedGoogle Scholar